Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
Clinical trial NCT05388760 · COMPLETED
Trial details
- NCT number
- NCT05388760
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-07
- Primary completion
- 2023-10-20
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.